The SMILE study: Study of long-term methotrexate and iguratimod combination therapy in early rheumatoid arthritis

The SMILE study: Study of long-term methotrexate and iguratimod combination therapy in early rheumatoid arthritis

Abstract. Background:. Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic inflammation and joint destruction. Iguratimod (IGU) is a novel conventional synthetic disease-modifying antirheumatic drugs (csDMARD) with good efficacy and safety for the treatment of active...

Full description

Saved in:
Bibliographic Details
Main Authors: Fang Du, Qing Dai, Jialin Teng, Liangjing Lu, Shuang Ye, Ping Ye, Zhiqian Lin, Hong Ding, Min Dai, Chunde Bao, On behalf of the SMILE Group, Xiangxiang Pan
Format: Article
Language:English
Published: Wolters Kluwer 2025-07-01
Series:Chinese Medical Journal
Online Access:http://journals.lww.com/10.1097/CM9.0000000000003200
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items